REGRESSION OF COLLAGEN-INDUCED ARTHRITIS WITH TAXOL, A MICROTUBULE STABILIZER

被引:65
作者
BRAHN, E
TANG, C
BANQUERIGO, ML
机构
[1] University of California, Los Angeles School of Medicine, Los Angeles, California
[2] UCLA, School of Medicine
[3] UCLA, School of Medicine
来源
ARTHRITIS AND RHEUMATISM | 1994年 / 37卷 / 06期
关键词
D O I
10.1002/art.1780370611
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To investigate the capacity of taxol, a microtubule stabilizer, to inhibit collagen-induced arthritis (CIA), a model of rheumatoid arthritis. Methods. Louvain rats were immunized with type LI collagen (day 0) to induce arthritis. Taxol was administered beginning on day 2 (prevention protocol) or at arthritis onset on day 9 (in either a high-dose or low-dose suppression protocol). Rats were assessed clinically and radiographically for arthritis severity. Cellular and humoral immune responses to type II collagen were also evaluated. Results. Institution of taxol prior to arthritis onset completely precluded the development of CIA (P < 0.0001 versus controls). It also suppressed established clinical disease (high-dose protocol P < 0.0000001; low-dose protocol P < 0.0001) and radiographic erosions (high-dose protocol P < 0.00001; low-dose protocol P < 0.001) compared with controls, Levels of IgG antibodies, but not delayed-type hypersensitivity, to type II collagen were reduced after taxol administration. Conclusion. Taxol completely prevented the induction of CIA and caused significant regression of existing arthritis.
引用
收藏
页码:839 / 845
页数:7
相关论文
共 27 条
  • [1] TAXOL, A MICROTUBULE-STABILIZING ANTINEOPLASTIC AGENT, INDUCES EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1 IN MACROPHAGES
    BOGDAN, C
    DING, A
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1992, 52 (01) : 119 - 121
  • [2] EFFECTS OF TAXOL ON THE MACROPHAGE FUNCTION - INTERACTIONS WITH SOME IMMUNOLOGICAL PARAMETERS
    BOTTEXGAUTHIER, C
    CONDEMINE, F
    PICOT, F
    VIDAL, D
    [J]. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1992, 14 (1-2) : 39 - 61
  • [3] BRAHN E, 1992, LYMPHOKINE CYTOK RES, V11, P253
  • [4] ANTIGEN-SPECIFIC SUPPRESSION OF COLLAGEN ARTHRITIS BY ADOPTIVE TRANSFER OF SPLEEN-CELLS
    BRAHN, E
    TRENTHAM, DE
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1984, 31 (01): : 124 - 131
  • [5] BRAHN E, 1991, CLIN ORTHOP RELAT R, V265, P42
  • [6] PHASE-II TRIAL OF TAXOL, AN ACTIVE-DRUG IN THE TREATMENT OF METASTATIC BREAST-CANCER
    HOLMES, FA
    WALTERS, RS
    THERIAULT, RL
    FORMAN, AD
    NEWTON, LK
    RABER, MN
    BUZDAR, AU
    FRYE, DK
    HORTOBAGYI, GN
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (24) : 1797 - 1805
  • [7] HORWITZ SB, 1992, TRENDS PHARMACOL SCI, V13, P134
  • [8] TAXOL INHIBITS N-FORMYL-METHIONYL-LEUCYL-PHENYLALANINE (FMLP)-INDUCED HUMAN NEUTROPHIL POLARIZATION AND H2O2 PRODUCTION WHILE DECREASING [H-3] FMLP BINDING
    IANNONE, MA
    WOLBERG, G
    REYNOLDSVAUGHN, R
    ZIMMERMAN, TP
    [J]. AGENTS AND ACTIONS, 1987, 21 (3-4): : 278 - 280
  • [9] PREVENTION OF EXPERIMENTAL AUTOIMMUNE ARTHRITIS WITH A PEPTIDE FRAGMENT OF TYPE-II COLLAGEN
    KU, G
    KRONENBERG, M
    PEACOCK, DJ
    TEMPST, P
    BANQUERIGO, ML
    BRAUN, BS
    REEVE, JR
    BRAHN, E
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (03) : 591 - 599
  • [10] KUMAR N, 1981, J BIOL CHEM, V256, P435